Alterity Therapeutics Limited

NCM: ATHE

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Alterity Therapeutics Limited's price action across multiple timeframes using regression channels and statistical scoring.

Get ATHE Z-Score →

About Alterity Therapeutics Limited

Healthcare Biotechnology

Alterity Therapeutics Limited is engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson's disease. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase II clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company also operates drug discovery platform that generates patentable chemical compounds to treat the underlying pathology of neurological diseases. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

📊 Fundamental Analysis

Alterity Therapeutics Limited demonstrates a profit margin of -219.9%, which is below the sector average, suggesting competitive pressure.

The company recently reported 74.6% revenue growth, which is well above average for the Healthcare sector.

Return on Equity (ROE) is -47.0%, which indicates that capital utilization is currently under pressure.

At a current price of $3.71, ATHE currently sits at the 24th percentile of its 52-week range (Range: $2.66 - $7.00).

🏥 Financial Health

🔴 Profit Margin Weak

✅ Debt/Equity Excellent

✅ Revenue Growth Excellent

🔴 Return on Equity Weak

✅ Beta (Risk) Low Volatility

Key Financials

Market Cap

$70.25M

Trailing P/E

Forward P/E

-9.39

Beta (5Y)

-0.07

52W High

$7.00

52W Low

$2.66

Avg Volume

13K

Day High

Day Low

Get ATHE Z-Score on Dashboard 🚀